Home Tags Keytruda

Tag: Keytruda

Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

Potential Accelerated Approval Enfortumab Vedotin + Pembrolizumab in Metastatic Urothelial Cancer

Peter Hofland, Ph.D -

Combination Enfortumab Vedotin + Pembrolizumab Granted Breakthrough Therapy in Bladder Cancer

Peter Hofland, Ph.D -

Enfortumab Vedotin + Pembrolizumab Shrink Tumors in the Majority of Bladder...

Peter Hofland, Ph.D -
Doctor discussing treatment options with a patient.

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

Andrea Maddox-Smith -
Human kidney cross section. Photo courtesy: 2019 Fotolia

Europe Adopts Pembrolizumab + Axitinib as First-Line Treatment for Advanced Renal...

Peter Hofland, Ph.D -

Pembrolizumab + Chemotherapy meets Primary Endpoint in Pivotal Phase III Trial...

Peter Hofland, Ph.D -

Pembrolizumab as 1st-line Therapy for Merkel Cell Carcinoma Shows Improved Survival

Peter Hofland, Ph.D -

Interim Phase II Results of DNX-2401 + Pembrolizumab for Glioblastoma ...

Danielle Garcia -

Pembrolizumab Improves Survival of Patients with Metastatic or Recurrent Head and...

Peter Hofland, Ph.D -

Nivolumab + Low-dose Ipilimumab may be First Line Treatment in Some...

Sonia Portillo -
12Page 1 of 2

LATEST

© 2020 Sunvalley Communication, LLC. All Rights Reserved.